Danaher | DHR - Actif À Court Terme

Prix De L'Action
174.63
Variation Quotidienne
0.59 0.34%
Mensuellement
-9.10%
Annuel
-8.11%
Q2 Prévisions
171.51




Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.66B 38.87M 2026-03
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Edwards Lifesciences USD 6.74B 380M 2025-12
ESCO Technologies USD 689.65M 1.15M 2025-12
Fortive USD 1.55B 58.5M 2026-03
Henry Schein USD 4.5B 32M 2026-03
Illumina USD 2.74B 551M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Keysight Technologies USD 4.7B 353M 2025-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Medtronic USD 24.07B 75M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.45B 80.6M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Roper Industries USD 1.91B 16M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Waters USD 1.99B 69.86M 2025-12
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03